Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AndroGel in ICU Acquired Hypogonadism
NCT03678233Phase 2Unknown
- Sponsor
- Centre Hospitalier Universitaire de Clermont-Ferrand
- Start
- Jun 2019
- Primary completion
- Jun 2025
- Countries
- 1
01
Overview
A Phase 2 trial of AndroForte in Hypogonadism, sponsored by Centre Hospitalier Universitaire de Clermont-Ferrand. Status: unknown.
02
Drugs
AndroForte
03
Conditions
Hypogonadism
Beyond the preview
Go deeper on NCT03678233.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03678233.